Open Access

Changes in MMP‑2, MMP‑9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis

  • Authors:
    • Xuesong Bai
    • Guang Bai
    • Lidong Tang
    • Lin Liu
    • Yufeng Li
    • Wei Jiang
  • View Affiliations

  • Published online on: April 30, 2020     https://doi.org/10.3892/etm.2020.8710
  • Pages: 269-274
  • Copyright: © Bai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Changes in matrix metalloproteinase (MMP)-2, MMP-9, inflammation, blood coagulation factors and intestinal mucosal permeability in patients with active ulcerative colitis (UC) were investigated. A total of 50 active UC patients treated in our hospital from January 2016 to December 2018 were selected as the UC group, whereas 50 normal subjects receiving physical examination were selected as the control group. Venous blood was drawn to detect the content of early predictors, C‑reactive protein (CRP), follistatin‑like protein 1 (FSTL1) and D‑dimer in serum. The disease activity index (DAI) score was recorded in both groups, the levels of MMP‑2 and MMP‑9 were determined, and the inflammatory factors interleukin (IL)‑1, IL‑6 and tumor necrosis factor (TNF)‑α were also detected. Moreover, the blood coagulation factors, platelet count, prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen level were detected, the content of lactulose (L) and mannitol (M) in the urine after oral administration of L and M test liquid was determined via high‑performance liquid chromatography in both groups, and the L/M ratio was calculated. In UC group, the content of CRP, FSTL1 and D‑dimer was significantly higher than that in the control group (P<0.05). The DAI score was significantly higher (P<0.05), the content of MMP‑2 and MMP‑9 was remarkably raised (P<0.05), the platelet count, PT, APTT and fibrinogen level were all obviously increased (P<0.05), and the L/M ratio was notably lower (P<0.05) in the UC group than in the control group. In patients with active UC, MMP‑2, MMP‑9 and inflammatory factors were significantly increased, and there were changes in the blood coagulation factors and intestinal mucosal permeability, which further promote the occurrence and development of UC.

Related Articles

Journal Cover

July 2020
Volume 20 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Bai, X., Bai, G., Tang, L., Liu, L., Li, Y., & Jiang, W. (2020). Changes in MMP‑2, MMP‑9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis. Experimental and Therapeutic Medicine, 20, 269-274. https://doi.org/10.3892/etm.2020.8710
MLA
Bai, X., Bai, G., Tang, L., Liu, L., Li, Y., Jiang, W."Changes in MMP‑2, MMP‑9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis". Experimental and Therapeutic Medicine 20.1 (2020): 269-274.
Chicago
Bai, X., Bai, G., Tang, L., Liu, L., Li, Y., Jiang, W."Changes in MMP‑2, MMP‑9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis". Experimental and Therapeutic Medicine 20, no. 1 (2020): 269-274. https://doi.org/10.3892/etm.2020.8710